Quantcast

Latest Exenatide Stories

2014-02-17 23:03:29

The Firm is investigating Byetta lawsuits on behalf of individuals who developed pancreatic cancer, thyroid cancer or pancreatitis, allegedly due to their use of the Type 2 diabetes medication. New York, New York (PRWEB) February 17, 2014 The federal court overseeing dozens of Byetta lawsuits (http://www.byettalawsuit.com) and other product liability claims involving Type 2 diabetes drugs known as incretin mimetics is now considering proposals for the case management of the...

2014-02-13 23:01:43

The Firm is evaluating Byetta lawsuits and other legal claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis, and thyroid cancer due their use of incretin mimetic medications used to treat Type 2 diabetes. New York, New York (PRWEB) February 13, 2014 As Byetta lawsuits (http://www.byettalawsuit.com) and other legal claims involving incretin mimetic drugs continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that U.S. health regulators...

2014-02-10 12:25:17

JERUSALEM, Feb. 10, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has submitted a protocol to the U.S. Food and Drug Administration (FDA) to initiate a Phase 2a trial of its orally ingestible insulin capsule, ORMD 0801, for type 1 diabetes. The protocol was submitted under Oramed's existing IND for ORMD-0801 to include both...

2014-01-30 04:22:02

Company to Move Forward with FDA Phase 2b Multi-Center Trial JERUSALEM, Jan. 30, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a developer of oral drug delivery systems, announced today results from its Phase 2a clinical trial for its ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes. The trial was conducted under a United States Food and Drug Administration (FDA) IND (Investigational New Drug) protocol. The Phase 2a study met all primary and...

2014-01-29 23:04:46

The Firm is currently evaluating Byetta lawsuits on behalf of individuals who allegedly developed pancreatic cancer, thyroid cancer, or pancreatitis due to their use of the Type 2 diabetes drugs. New York, New York (PRWEB) January 29, 2014 As Byetta lawsuits (http://www.byettalawsuit.com ) continue to mounts in courts around the country, Bernstein Liebhard LLP notes that plaintiffs in federally-filed lawsuits involving allegations that use of the drug caused thyroid cancer have filed a...

2014-01-27 08:28:47

JERUSALEM, January 27, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. [http://www.oramed.com ] (NASDAQCM: ORMP) ( http://www.oramed.com), a developer of oral drug delivery systems, announced today that it will announce the results of its Phase 2a clinical trial for the company's ORMD-0801 [http://www.oramed.com/index.php?page=14 ] oral insulin capsule for the treatment of type 2 diabetes on January 30, 2014. Oramed CEO Nadav Kidron will present the findings at an investor...

2014-01-25 23:02:06

The Firm is investigating Byetta lawsuits that allege an association between the use of Byetta and pancreatic cancer, as well as pancreatitis and thyroid cancer. New York, New York (PRWEB) January 25, 2014 Product liability claims alleging, among other things, an association between diabetes drugs like Byetta and pancreatic cancer (http://www.byettalawsuit.com/byetta-pancreatic-cancer/) continue to move forward in state and federal courts around the country, Bernstein Liebhard LLP...

2014-01-23 23:29:58

National network of lawyers will resume availability for inquiries from consumers seeking compensation in lawsuits alleging links between diabetes medications Victoza, Janumet, Januvia and Byetta and pancreatic cancer. San Diego, CA (PRWEB) January 23, 2014 http://www.resource4thepeople.com/defectivedrugs/victoza-lawsuit.html Resource4thePeople announced today that its national network of attorneys will continue to offer free consultations in 2014 to consumers inquiring about allegations...

2014-01-22 23:30:56

National network of lawyers will resume availability for inquiries from consumers seeking compensation in lawsuits alleging links between diabetes medications Janumet, Januvia, Byetta and Victoza and pancreatic cancer. San Diego, CA (PRWEB) January 22, 2014 http://www.resource4thepeople.com/defectivedrugs/januvia.html Resource4thePeople announced today that its national network of attorneys will continue to offer free consultations in 2014 to consumers inquiring about allegations in...

2014-01-21 23:28:42

National network of lawyers will resume availability for inquiries from consumers seeking compensation in lawsuits alleging links between diabetes medications Byetta, Januvia, Janumet and Victoza and pancreatic cancer. San Diego, CA (PRWEB) January 21, 2014 http://www.resource4thepeople.com/defectivedrugs/byetta.html Resource4thePeople announced today that its national network of attorneys will continue to offer free consultations in 2014 to consumers inquiring about allegations in...


Latest Exenatide Reference Libraries

36_67c6fec75293d7e1e91a0c52aa692cf7
2005-06-22 14:17:05

The Gila monster (Heloderma suspectum) is one of the two known species of venomous lizards. This lizard lives in the deserts of the southwestern USA and northwestern Mexico. It is a heavy, slow moving lizard and can measure up to 2 feet (60 cm) in length. Its skin has the appearance of beads in the colors black, pink, orange, and yellow, laid down in intricate patterns across the animal's body. Unlike a snake, the Gila monster envenomates its victim through grooves in the teeth of its...

More Articles (1 articles) »
Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related